Filed: 2/17/2026ACC: 0001104659-26-015687
📋 What this filing means
DCVC OPPORTUNITY FUND II GP, LLC filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $16.59M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$16.59M
Total AUM (reported)
3.96M
Total Shares
Allocation by class
CL A$16.59M100.0%
Portfolio Concentration
Top 3$16.59M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 3.96M
Sole
Full voting authority
3.96M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
Recursion Pharmaceuticals, Inc.
SOLEShares3.95M
TypeSH
Market value$16.16M
97.42%
Sole
3.95M
Shared
0.00
None
0.00
IonQ, Inc.
SOLEShares9.52K
TypeSH
Market value$427.2K
2.58%
Sole
9.52K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc.SOLE | CL A | 3.95M | SH | $16.16M 97.42% | 3.95M | 0.00 | 0.00 |
IonQ, Inc.SOLE | CL A | 9.52K | SH | $427.2K 2.58% | 9.52K | 0.00 | 0.00 |